Literature DB >> 24696706

Advances in serous tubal intraepithelial carcinoma: correlation with high grade serous carcinoma and ovarian carcinogenesis.

Hong-Xia Li1, Zhao-Hui Lu2, Keng Shen3, Wen-Jun Cheng4, Anais Malpica5, Jing Zhang6, Jian-Jun Wei7, Zhi-Hong Zhang8, Jinsong Liu1.   

Abstract

Early serous carcinoma in fallopian tube or serous tubal intraepithelial carcinoma (STIC), an early lesion limited to the epithelium of the fallopian tube and firstly identified from specimen obtained by prophylactic salpingo-oophorectomy, has provided insight into pelvic high grade serous carcinoma (HGSC). Increasing evidence indicates that STIC is a likely precursor for HGSC and several studies have focused on this lesion and its clinical significance. This review addresses recent advances in recognizing STIC and its correlation with HGSC and ovarian carcinogenesis. It also describes evidence regarding the fallopian tube as a source of some HGSCs, the protocol for optimizing histological evaluation of the tubes, the spectrum of tubal lesions from benign to noninvasive carcinoma, changes in diagnostic criteria from purely morphologic characteristics to a combination of morphologic features and molecular biomarkers, and new studies about potential biomarkers. However, the direct evidence regarding STIC as the precursor of HGSC is still tantalizing due to other possibilities that may also explain the origin of pelvic HGSC. Further molecular genetic studies are required to address this important question.

Entities:  

Keywords:  Serous tubal intraepithelial carcinoma; carcinogenesis; fallopian tube; high grade serous carcinoma; ovarian cancer

Mesh:

Year:  2014        PMID: 24696706      PMCID: PMC3971287     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  69 in total

1.  Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes.

Authors:  R R Barakat; M G Federici; P E Saigo; M E Robson; K Offit; J Boyd
Journal:  Cancer       Date:  2000-07-15       Impact factor: 6.860

2.  Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.

Authors:  J B Welsh; P P Zarrinkar; L M Sapinoso; S G Kern; C A Behling; B J Monk; D J Lockhart; R A Burger; G M Hampton
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

3.  Expression of the alpha2beta1 and alpha3beta1 integrins at the surface of mesothelial cells: a potential attachment site of endometrial cells.

Authors:  C A Witz; A Takahashi; I A Montoya-Rodriguez; S Cho; R S Schenken
Journal:  Fertil Steril       Date:  2000-09       Impact factor: 7.329

Review 4.  Structure and function of the HMGI(Y) family of architectural transcription factors.

Authors:  R Reeves
Journal:  Environ Health Perspect       Date:  2000-10       Impact factor: 9.031

5.  HMGA2 gene is a promising target for ovarian cancer silencing therapy.

Authors:  Anastasia Malek; Elena Bakhidze; Aurelia Noske; Christine Sers; Achim Aigner; Reinhold Schäfer; Oleg Tchernitsa
Journal:  Int J Cancer       Date:  2008-07-15       Impact factor: 7.396

Review 6.  New insights into the pathogenesis of serous ovarian cancer and its clinical impact.

Authors:  Keren Levanon; Christopher Crum; Ronny Drapkin
Journal:  J Clin Oncol       Date:  2008-10-14       Impact factor: 44.544

Review 7.  Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective.

Authors:  E A Jarboe; A K Folkins; R Drapkin; T A Ince; E S Agoston; C P Crum
Journal:  Histopathology       Date:  2008-02-22       Impact factor: 5.087

8.  Deletion of Dicer in somatic cells of the female reproductive tract causes sterility.

Authors:  Ankur K Nagaraja; Claudia Andreu-Vieyra; Heather L Franco; Lang Ma; Ruihong Chen; Derek Y Han; Huifeng Zhu; Julio E Agno; Preethi H Gunaratne; Francesco J DeMayo; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2008-08-07

9.  HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma.

Authors:  Alexandra C Hristov; Leslie Cope; Marcelo Delos Reyes; Mansher Singh; Christine Iacobuzio-Donahue; Anirban Maitra; L M S Resar
Journal:  Mod Pathol       Date:  2008-08-29       Impact factor: 7.842

10.  Fallopian tube intraluminal tumor spread from noninvasive precursor lesions: a novel metastatic route in early pelvic carcinogenesis.

Authors:  Jonathan G Bijron; Cornelis A Seldenrijk; Ronald P Zweemer; Joost G Lange; René H M Verheijen; Paul J van Diest
Journal:  Am J Surg Pathol       Date:  2013-08       Impact factor: 6.394

View more
  9 in total

1.  Pathology findings and clinical outcomes after risk reduction salpingo-oophorectomy in BRCA mutation carriers: a multicenter Spanish study.

Authors:  L Minig; S Cabrera; R Oliver; A Couso; M J Rubio; S Iacoponi; M B Martin-Salamanca; S Carballo-Rastrilla; J M Cádenas-Rebollo; A García-Garcia; B Gil-Ibáñez; M J Juan-Fita; M G Patrono
Journal:  Clin Transl Oncol       Date:  2018-04-05       Impact factor: 3.405

2.  The conceptual advances of carcinogenic sequence model in high-grade serous ovarian cancer.

Authors:  Hiroshi Kobayashi; Kana Iwai; Emiko Niiro; Sachiko Morioka; Yuki Yamada; Kenji Ogawa; Naoki Kawahara
Journal:  Biomed Rep       Date:  2017-07-27

Review 3.  Fallopian tube initiation of high grade serous ovarian cancer and ovarian metastasis: Mechanisms and therapeutic implications.

Authors:  Tova M Bergsten; Joanna E Burdette; Matthew Dean
Journal:  Cancer Lett       Date:  2020-02-15       Impact factor: 8.679

Review 4.  Options in Prophylactic Surgery to Prevent Ovarian Cancer in High-Risk Women: How New Hypotheses of Fallopian Tube Origin Influence Recommendations.

Authors:  Casey L Swanson; Jamie N Bakkum-Gamez
Journal:  Curr Treat Options Oncol       Date:  2016-05

5.  Primary carcinoma of the fallopian tubes: Analysis of sixteen patients.

Authors:  Meryem Eken; Osman Temizkan; Ecmel Işık Kaygusuz; Dilşad Herkiloğlu; Ebru Çöğendez; Ateş Karateke
Journal:  Turk J Obstet Gynecol       Date:  2015-06-15

6.  Iron addiction: a novel therapeutic target in ovarian cancer.

Authors:  D Basuli; L Tesfay; Z Deng; B Paul; Y Yamamoto; G Ning; W Xian; F McKeon; M Lynch; C P Crum; P Hegde; M Brewer; X Wang; L D Miller; N Dyment; F M Torti; S V Torti
Journal:  Oncogene       Date:  2017-03-20       Impact factor: 9.867

7.  Focal Serous Tubal Intra-Epithelial Carcinoma Lesions Are Associated With Global Changes in the Fallopian Tube Epithelia and Stroma.

Authors:  Jingni Wu; Yael Raz; Maria Sol Recouvreux; Márcio Augusto Diniz; Jenny Lester; Beth Y Karlan; Ann E Walts; Arkadiusz Gertych; Sandra Orsulic
Journal:  Front Oncol       Date:  2022-03-21       Impact factor: 5.738

8.  Incidence of pelvic high-grade serous carcinoma after isolated STIC diagnosis: A systematic review of the literature.

Authors:  Valerie Catherine Linz; Amelie Löwe; Josche van der Ven; Annette Hasenburg; Marco Johannes Battista
Journal:  Front Oncol       Date:  2022-08-31       Impact factor: 5.738

9.  PAX2 maintains the differentiation of mouse oviductal epithelium and inhibits the transition to a stem cell-like state.

Authors:  Kholoud Alwosaibai; Atefeh Abedini; Ensaf M Al-Hujaily; Yong Tang; Kenneth Garson; Olga Collins; Barbara C Vanderhyden
Journal:  Oncotarget       Date:  2017-08-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.